Abbott Laboratories
ABT
#86
Rank
NZ$324.32 B
Marketcap
NZ$186.64
Share price
-0.27%
Change (1 day)
-18.90%
Change (1 year)
Categories

Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.

EPS for Abbott Laboratories (ABT)

EPS in 2025 (TTM): NZ$6.41

According to Abbott Laboratories's latest financial reports the company's current EPS (TTM) is NZ$6.35. In 2024 the company made an earnings per share (EPS) of NZ$13.09 an increase over its 2023 EPS that were of NZ$5.58.

EPS history for Abbott Laboratories from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$6.41-51%
2024NZ$13.09134.51%
2023NZ$5.58-23.23%
2022NZ$7.277.5%
2021NZ$6.7657.41%
2020NZ$4.3021.54%
2019NZ$3.5454.75%
2018NZ$2.28389.07%
2017NZ$0.47-71.01%
2016NZ$1.61-68.01%
2015NZ$5.0496.13%
2014NZ$2.57-8.64%
2013NZ$2.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.85 197.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.46 96.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.30-63.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.28-1.04%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
NZ$30.08 374.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$3.32-47.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$4.11-35.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.03-20.78%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$9.06 42.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$6.38 0.51%๐Ÿ‡ฌ๐Ÿ‡ง UK